First human age-reversal trial underway
Sinclair's lab is conducting the first FDA-approved human clinical trial using OSK gene-therapy capsules injected into the eyes of glaucoma patients.
Where this was said
The OSK Gene Therapy and First Human Trial
At 7:57 · chapter starts 5:13
In a remarkable moment of science communication, Sinclair produces a spiked rubber ball from his pocket to illustrate the virus-like particle his lab has engineered to deliver youth-restoring genes into human eyes. The capsule, he explains, carries three genes called OSK — a modified version of Shinya Yamanaka's Nobel Prize-winning reprogramming cocktail — along with surface proteins that target it to specific tissues. The first human patient, nearly totally blind from glaucoma, received trillions of these capsules injected into his eye earlier this year, bravely volunteering to be first. Nothing has gone wrong. Sinclair explains the scientific rationale: every cell in the human body still carries an intact backup copy of its youthful programming. OSK reads and reinstalls that backup, returning 92-year-old cells to a 25-year-old state while preserving their identity — a crucial difference from the full Yamanaka reset that creates dangerous stem cells.
The First Human Age-Reversal Trial Is Happening Right Now
Sinclair's lab is running the first FDA-approved human trial to reverse aging using virus-like capsules carrying OSK genes. The first patient — nearly totally blind — received trillions of these capsules injected into his eye, and so far nothing has gone wrong.
The Backup Copy of Youth Inside Every Human Cell
Every cell in your body still carries an intact backup copy of the instructions that made you young. OSK gene therapy reads that backup and reinstalls it — turning 92-year-old cells back to their 25-year-old state without erasing their identity or causing cancer.
How Aging Reversal Was Achieved Without Creating Stem Cells
Shinya Yamanaka won the Nobel Prize for turning adult cells into stem cells using 4 genes — but stem cells have no identity and would kill you. Sinclair's team found that using only 3 of those genes (OSK, leaving out M) reverses aging 75-80% without erasing cell identity.
Similar snapshots
540M years ago: first animal vision
Animals first sensed light 540 million years ago, triggering an evolutionary acceleration known as the Cambrian explosion within 10 million years.
50% of cortex involved in vision
It is estimated that half of all cortical activity in the human brain is involved in visual function, underscoring vision's central role in intelligence.
Human 6-year-olds learn tens of thousands of object categories
Cognitive neuroscience literature shows that by age 6, humans can recognize tens of thousands of different object categories — far more data than early AI systems were trained on.
~3% of FDA drugs have unclear mechanisms
Only about 3% of FDA-approved drugs have genuinely unclear mechanisms of action, making an unknown mechanism a meaningful early red flag for any compound.
30–50% of phase 1 drugs fail to reach phase 2
Even compounds that clear preclinical testing often fail in humans: 30 to 50% of drugs entering phase 1 trials do not advance to phase 2, frequently because human behavior differs from animal models.
BPC-157 published work: >80% from one group
More than 80% of published BPC-157 research comes from a single academic group whose researchers have IP and commercial interests connected to the molecule, limiting independent replication.
~100 approved peptide drugs; ~150 in trials
Roughly 100 peptide drugs are already FDA-approved, about 150 more are in clinical trials, and 600–700 are in preclinical development, underscoring the legitimacy of peptide science broadly.
BPC-157 founder withheld screening method
The scientist who discovered BPC-157 refused to disclose the screening method used to identify the compound and has never fully published the parent protein sequence — what Peter Attia calls 'scientific trust me, bro.'
Brain barely distinguishes imagined vs real
The brain's visual, auditory, and motor cortices light up nearly identically whether an experience is real or imagined, making visualization a form of actual neural training.
